in Joint Sponsorship with
National Stroke Association
Preventing Recurrent Stroke: Targets for Managing Risk
Original Event Date: September 23, 2009 12 PM Eastern
Accreditation for program has expired.
Information included in the program may become dated as new research and guidelines become available. It is the responsibility of the viewer to determine current evidence-based methods and procedures in treating patients.
Philip B. Gorelick, MD MPH, FACP*
John S. Garvin Professor and Head
Director, Center for Stroke Research
Fernando Testai, MD, PhD*
Assistant Professor of Neurology
Section of Cerebrovascular Disease and Neurological Critical Care
*Department of Neurology and Rehabilitation
University of Illinois College of Medicine at Chicago
The purpose of this activity is to narrow the gap between knowledge and practice for recurrent stroke risk. Faculty present the incidence of recurrent stroke and describe the financial and social burden of stroke within the United States. The content covers practice targets to significantly reduce stroke risk through guidelines-based clinical practice. Faculty also describe strategies to improve patient adherence. The program concludes with a brief update on recent, evidence-based advances in preventing recurrent stroke.
Neurologists, Emergency Department Physicians, Hospitalists, Primary Care Physicians, and Internists
Upon completion of the activity, participants should be able to:
- Identify evidence-based strategies to reduce recurrent strokes
- Implement evidence-based practical interventions to manage stroke risk factors to reduce recurrent stroke
- Implement tactics to improve patient adherence to recurrent stroke prevention strategies
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Illinois at Chicago (UIC) College of Medicine and National Stroke Association. The University of Illinois at Chicago (UIC) College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Illinois at Chicago (UIC) College of Medicine designates this Enduring Material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dr. Gorelick has served as a consultant,steering committee member, and speaker’s bureau member for Boehringer Ingelheim, as a consultant to BMS-Sanofi and as an adjudication committee member for Pfizer.
Dr. Testai has nothing to disclose.
This program is supported by an education grant from Bristol-Myers-Squibb/Sanofi Pharmaceuticals Partnership